News
-
Lilly ANZ policy head leaves for mental health gig
- Wed Aug 26
After an impressive stint in pharma that saw Lilly take a fresh approach to media and access, Katherine Burchfield has left to lead a mental health service.
Read more -
PBS reform? That’s not part of Comley’s plan
- Wed Aug 26
The Department’s 2026-27 Corporate Plan targets aged care, NDIS reform, but when it comes to the PBS, access is irrelevant and affordability is everything.
Read more -
Who’s looking for a Country Manager?
- Wed Aug 26
Another company has commenced the hunt for a new Country Manager. Given its ongoing struggle for reimbursement, it may prove a tough gig.
Read more -
Aussie patients wait for homegrown therapy
- Wed Aug 26
Europe secures access to the first and only approved Rett syndrome treatment joining the US and Canada, but there’s no sign of a TGA dossier.
Read more -
PBAC doubles-down on its value demands
- Mon Aug 24
PBAC recommended two out of three submissions, its decision-making demonstrating how even with high unmet need, price is what matters most.
Read more -
Sparse field for MA Board race as MDs opt out
- Mon Aug 24
Nominations for Medicines Australia Board vacancies are opened and while many big names say they won’t run, a couple have expressed some interest.
Read more -
Is PBAC finally measuring up, or just hitting out?
- Mon Aug 24
Industry pushed for better metrics on PBS listings. The PBAC has finally obliged, but this is unlikely to be what anyone asked for.
Read more -
UK fast-funding decision puts Australia to shame
- Mon Aug 24
NICE approves broad NHS coverage for weekly injectable four months after Australia failed to ink a deal to fund the same weekly therapy.
Read more